Last reviewed · How we verify
Allochrysine (aurotioprol)
Allochrysine (generic name: aurotioprol) is a aurotioprol drug. It is currently in unknown development.
Allochrysine is thought to work by interacting with a specific biological target, although the exact mechanism is not well understood.
Allochrysine is a small molecule with synonyms including Aurothioprol, Aurotioprol, and Aurothiopropanol Sodium Sulfonate. It is used as an antirheumatic agent.
At a glance
| Generic name | aurotioprol |
|---|---|
| Drug class | aurotioprol |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like locks, and Allochrysine is a key that fits into one of those locks. When it binds to the lock, it can either turn it on or off, depending on the type of lock and the key's shape. This can affect how cells behave and communicate with each other.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allochrysine CI brief — competitive landscape report
- Allochrysine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Allochrysine
What is Allochrysine?
How does Allochrysine work?
What is the generic name of Allochrysine?
What drug class is Allochrysine in?
What development phase is Allochrysine in?
Related
- Drug class: All aurotioprol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing